Corcept Therapeutics, Inc. (CORT)
35.70
-0.08
(-0.22%)
USD |
NASDAQ |
Feb 27, 16:00
35.71
+0.01
(+0.03%)
Pre-Market: 20:00
Corcept Therapeutics Research and Development Expense (TTM) : 254.91M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Axsome Therapeutics, Inc. | 182.48M |
| United Therapeutics Corp. | 550.00M |
| Harrow, Inc. | 13.97M |
| Ultragenyx Pharmaceutical, Inc. | 714.72M |
| Amneal Pharmaceuticals, Inc. | 187.59M |